The latest in systemic therapy for advanced HCC
Ghassan Abou-Alfa, MD, MBA, talks about the latest in systemic therapy for advanced hepatocellular carcinoma (HCC) at the 2018 ASCO Annual Meeting
Author: obr
Added: 07/19/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 19, 2018 Category: Cancer & Oncology Source Type: podcasts
Sensitivity for BCLC for Stage A was 93% & #124; Detect Hepatocellular Carcinoma Lesions in Future
Dr. John Kisiel, MD, Mayo Clinic, talks Sensitivity for BCLC for Stage A was 93%| Detect Hepatocellular Carcinoma Lesions in Future for DDW 2018.
Author: Cancer-News
Added: 07/16/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 16, 2018 Category: Cancer & Oncology Source Type: podcasts
Develop Novel, Non-Invasive Biomarkers | Clinical Validation Study in Hepatocellular Carcinoma
Dr. John Kisiel, MD, Mayo Clinic, talks about Develop Novel, Non-Invasive Biomarkers | Clinical Validation Study in Hepatocellular Carcinoma for DDW 2018.
Author: Cancer-News
Added: 07/16/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 16, 2018 Category: Cancer & Oncology Source Type: podcasts
Riccardo Lencioni, MD, FSIR, EBIR - At the Intersection of Local and Systemic Therapy in the Management of Hepatocellular Carcinoma: Preparing for the Next Evolution in Multimodal Treatment
At the Intersection of Local and Systemic Therapy in the Management of Hepatocellular Carcinoma: Preparing for the Next Evolution in Multimodal Treatment (Source: PeerView CME/CE Audio Podcast - Immunology)
Source: PeerView CME/CE Audio Podcast - Immunology - May 28, 2018 Category: Allergy & Immunology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts
Ghassan Abou-Alfa, MD, MBA - Teaming Up to Improve Outcomes in Advanced Hepatocellular Carcinoma: A Tumor Board Evaluating the Potential of Immunotherapy and Novel Targeted Approaches
Teaming Up to Improve Outcomes in Advanced Hepatocellular Carcinoma: A Tumor Board Evaluating the Potential of Immunotherapy and Novel Targeted Approaches (Source: PeerView CME/CE Audio Podcast - Gastroenterology)
Source: PeerView CME/CE Audio Podcast - Gastroenterology - May 2, 2018 Category: Gastroenterology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts
Ghassan Abou-Alfa, MD, MBA - New Options, Emerging Combinations in Advanced Hepatocellular Carcinoma: Are Management Approaches Poised For Transformation?
New Options, Emerging Combinations in Advanced Hepatocellular Carcinoma: Are Management Approaches Poised For Transformation? (Source: PeerView CME/CE Audio Podcast - Immunology)
Source: PeerView CME/CE Audio Podcast - Immunology - April 13, 2018 Category: Allergy & Immunology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts
New Guidelines for HCC: The Big Questions Tackled
Dr David Johnson provides clinicians with an overview of the new guidelines from the American Association for the Study of Liver Diseases (AASLD) on hepatocellular carcinoma. (Source: Medscape Gastroenterology Podcast)
Source: Medscape Gastroenterology Podcast - February 21, 2018 Category: Gastroenterology Authors: Medscape Source Type: podcasts
Whiteboard Video: The Epidemiology of Hepatocellular Carcinoma and Current Standard of Care
Tyrosine kinase inhibitors (TKIs) are orally active, small molecules that exhibit antitumor activity by targeting enzymes that play a critical role cellular functions, including modulation of growth f...
Author: imedex
Added: 02/06/2018 (Source: Oncology Tube)
Source: Oncology Tube - February 6, 2018 Category: Cancer & Oncology Source Type: podcasts
Velocity Vlog: Role of TKIs in Hepatocellular Carcinoma - Recent Updates
In this Velocity Vlog activity, Dr. Richard S. Finn of the UCLA Geffen School of Medicine, provides a brief overview of the epidemiology of hepatocellular carcinoma and then discusses current standar...
Author: imedex
Added: 02/06/2018 (Source: Oncology Tube)
Source: Oncology Tube - February 6, 2018 Category: Cancer & Oncology Source Type: podcasts
The Use And Sequencing Of Tyrosine Kinase Inhibitors(TKIs) In Hepatocellular Carcinoma (HCC)
Only one TKI is approved in a first line setting. Joining us from the 2018 Gastrointestinal Cancers Symposium is Dr. Richard Kim, MD, Gastrointestinal Oncology Department, Moffitt Cancer Center, Assis...
Author: obr
Added: 01/30/2018 (Source: Oncology Tube)
Source: Oncology Tube - January 30, 2018 Category: Cancer & Oncology Source Type: podcasts
Hepatocelluar Carcinoma (HCC) Treatment Response Through Imaging Assessment
Determining the progression and the responses of Hepatocellular Carcinoma (HCC). Professor Andrew X. Zhu, MD, PhD from Harvard Medical School and also the Director of Liver Cancer Research, comes to u...
Author: obr
Added: 01/29/2018 (Source: Oncology Tube)
Source: Oncology Tube - January 29, 2018 Category: Cancer & Oncology Source Type: podcasts
HCC under the microscope: From bench to bedside
In this presentation from the 'Looking Closely at New Therapeutic Options for Hepatocellular Carcinoma', Dr. Bruno Daniele discusses the latest advances in translational medicine for hepatocellular ca...
Author: imedex
Added: 01/11/2018 (Source: Oncology Tube)
Source: Oncology Tube - January 11, 2018 Category: Cancer & Oncology Source Type: podcasts
New treatment approaches for advanced, unresectable HCC
In this presentation from the 'Looking Closely at New Therapeutic Options for Hepatocellular Carcinoma', Dr. Jordi Bruix discusses novel treatment approaches for patients with advanced, unresectable h...
Author: imedex
Added: 01/11/2018 (Source: Oncology Tube)
Source: Oncology Tube - January 11, 2018 Category: Cancer & Oncology Source Type: podcasts
New developments in locoregional treatments for HCC
In this presentation from the 'Looking Closely at New Therapeutic Options for Hepatocellular Carcinoma', Dr. Luigi Bolondi discusses the latest advancements in locoregional therapy for patients with h...
Author: imedex
Added: 01/11/2018 (Source: Oncology Tube)
Source: Oncology Tube - January 11, 2018 Category: Cancer & Oncology Source Type: podcasts
Ghassan Abou-Alfa, MD, MBA - The Expanding Role of the Hepatologist in Interdisciplinary Hepatocellular Carcinoma Management: Achieving the Full Potential of Targeted Therapy and Immunotherapy Advances
The Expanding Role of the Hepatologist in Interdisciplinary Hepatocellular Carcinoma Management: Achieving the Full Potential of Targeted Therapy and Immunotherapy Advances (Source: PeerView Press CME/CE International Audio Podcast - Internal Medicine)
Source: PeerView Press CME/CE International Audio Podcast - Internal Medicine - December 8, 2017 Category: Internal Medicine Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts
